CA 125 and CEA, individually and in association, for a cutoff value of 107.6 U/mL and 2.0 ng/mL, respectively, could be used to predict progression of disease and mortality within a year of the staging laparoscopy in GC patients. The gene discussed is CEACAM5; the disease is gastric cancer.